Bellevue Biotech DT CHF/ CH0113817123 /
| NAV10/17/2024 | Chg.-8.9700 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 3,773.6699CHF | -0.24% | reinvestment | Equity | Swisscanto Fondsl. ▶ |
| Name | ISIN | Performance | Volatility | Sharpe ratio | ||
|---|---|---|---|---|---|---|
| 1. | J.Henderson H.BioTech.F.IU2 | LU1897414568 | +47.61% | 22.12% | 2.01 | |
| 2. | Abaris Biotech.Opportunities A USD | LU2210105313 | +85.60% | 41.06% | 2.01 | |
| 3. | J.Henderson H.BioTech.F.H2 | LU1897414485 | +47.40% | 22.09% | 2.00 | |
| 4. | J.Henderson H.BioTech.F.A2 | LU1897414303 | +46.75% | 22.12% | 1.97 | |
| 5. | Janus Henderson Horizon Biotechnology Fund IU2 EUR | LU2441282626 | +43.27% | 20.82% | 1.92 | |
| 6. | Janus Henderson Horizon Biotechnology Fund H2 HEUR | LU2441283277 | +45.13% | 22.19% | 1.89 | |
| 7. | Janus Henderson Horizon Biotechnology Fund A2 EUR | LU2441282899 | +42.94% | 21.15% | 1.88 | |
| 8. | Abaris Biotech.Opportunities A EUR | LU2210105669 | +77.88% | 39.85% | 1.87 | |
| 9. | Janus Henderson Horizon Biotechnology Fund A2 HEUR | LU2441282972 | +44.12% | 22.11% | 1.85 | |
| 10. | Abaris Biotech.Opportunities A CHF | LU2210124454 | +77.71% | 40.88% | 1.82 | |
| ... | ||||||
| 72. | Bellevue Biotech DT CHF | CH0113817123 | +15.12% | 18.27% | 0.65 | |
| Performance | Volatility | Sharpe ratio |
|---|---|---|
